ABSTRACT6-Nitroso-1,2-benzopyrone and 3-nitrosobenzamide, two C-nitroso compounds that inactivate the eukaryotic nuclear protein poly(ADP-ribose) polymerase [NAD+:poly(adenosine diphosphate D-ribose) ADP-D-ribosyltransferase, ADPRT, EC 2.4.2.30] at one zinc-ringer site, completely suppressed the proliferation of leukemic and other malignant human cells and subsequently produced cell death. Tumoricidal concentrations of the drugs were relatively harmless to normal bone marrow progenitor cells and to superoxide formation by neutrophil granulocytes. The cellular mechanism elicited by the C-nitroso compounds consists of apoptosis due to DNA degradation by the nuclear calcium/magnesiumdependent endonuclease. This endonuclease is maintained in a latent form by poly(ADP-ribosyl)ation, but inactivation of ADPRT by C-nitroso drugs derepresses the DNA-degrading activity. ADPRT is thus identified as a critical regulatory enzyme component of a DNA-binding multiprotein system that plays a central function in defining DNA structures in the intact cell.In pursuing the biological consequences of the inhibition of poly(ADP-ribose) polymerase [NAD+ :poly(adenosine diphosphate D-ribose) ADP-D-ribosyltransferase, ADPRT, EC 2.4.2.30] within intact cells we have developed a group of C-nitroso-substituted molecules that are the oxidation products of previously described ligands containing amino groups (1). These C-nitroso ligands uniquely oxidize one of the zinc fingers of ADPRT, resulting in zinc ion ejection and concomitant inactivation of the poly(ADP-ribosyl)ation activity of ADPRT without abrogating its binding to DNA (1). In the present paper we demonstrate a cytostatic and apoptotic action of two of these ADPRT ligands, 6-nitroso-1,2-benzopyrone (NOBP) and 3-nitrosobenzamide (NOBA), ¶ toward malignant human cells. The apoptotic effect was traced to the derepression of a calcium/magnesiumdependent endonuclease that under resting conditions is known to be inhibited by poly(ADP-ribosyl)ation (2). (85 Ci/mmol; 1 Ci = 37 GBq) was added per well and its incorporation into DNA following an 18-hr incubation was determined radiochemically (6). Proliferation was also monitored by direct cell counting. Since both assays were in agreement, the more convenient radiochemical test was used routinely. The tetrazolium reduction assay for cell viability (7), which was originally developed as a test for mitochondrial succinate dehydrogenase (8), was compared with trypan blue uptake and plating efficiency, and on the basis of positive correlation among the three assays, the more quantitative dye reduction method was adopted.
MATERIALS AND METHODSClonigenic Studies. Human 855-2 and HL-60 leukemic cells were plated at 105 per ml and human and rhesus bone marrow mononuclear cells and human peripheral stem cells at 4 x 105 per ml, and assays for colony-forming units were performed as reported (5). A semiquantitative assessment of malignant cells in bone marrow specimens was done by flow cytometry with labeled fluorescein-conjugated antibodies against ...